Indications
For active immunisation of dogs of six months of age or older against Babesia canis to reduce the severity of clinical signs associated with acute babesiosis (B. canis) and anaemia as measured by packed cell volume. Onset of immunity: Three weeks after the basic vaccination course. Duration of immunity: Six months after the last (re-)vaccination.
Composition
- Active substance
- babesia canis, inactivated, babesia rossi, inactivated
- International name (INN)
- vaccine against babesiosis in dogs
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Nobivac Piro
- Active substance
- babesia canis, inactivated, babesia rossi, inactivated
- Group
- Veterinary medicines
- Marketing authorisation holder